Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
NewsStarting October 22, new US Customs and Border Protection rules could cut off or severely limit mail-order prescription drug imports from Canada — a lifeline for millions of cost-burdened Americans. Patient advocates are sounding the alarm, warning that vulnerable patients may be forced to ration or skip essential medications. Lawmakers are pushing back, but federal agencies have yet to clarify the impact.
New US Customs and Border Protection regulations taking effect October 22 could disrupt or completely halt mail-order prescription drug deliveries from Canada to American patients. The rules — originally aimed at curbing illegal drug imports — now require medications mailed from abroad to clear a customs process involving a licensed broker and a financial guarantee, a bar that virtually no individual mail-order prescription has ever had to meet. Patient advocates are calling it an emergency, warning that uninsured and underinsured Americans who rely on Canadian pharmacies for affordable maintenance medications could be left without options.
The stakes are high: an estimated 2.3 million Americans buy prescription drugs from abroad, with Canadian pharmacies being a primary source. These patients tend to be older, lower-income, uninsured, or in poor health — those least able to absorb the cost difference. Canadian drugs can cost a fraction of their US equivalents, and federal agencies have so far offered no public guidance on whether exceptions will be made.
By the Numbers:
Why it matters: For clinicians, this is a moment to proactively discuss medication affordability with patients. Physicians should be prepared to explore therapeutic alternatives, patient assistance programs, and drug coupons for patients who may suddenly lose access to their current regimens.
